Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Shilpa Medicare gets 10 observations from USFDA for Jadcherla plant

      Shilpa Medicare gets 10 observations from USFDA for Jadcherla plant

      Ruby Khatun Khatun6 Dec 2017 10:00 AM IST
      New Delhi: Drug firm Shilpa Medicare said it has received 10 observations from the US health regulator for its formulation facilities at Jadcherla in...
      Trial results of Zika vaccine Sanofi dropped show promise

      Trial results of Zika vaccine Sanofi dropped show promise

      Ruby Khatun Khatun6 Dec 2017 9:45 AM IST
      CHICAGO: A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of...
      Roche

      Roche's Foundation Medicine wins FDA approval for new cancer test

      Ruby Khatun Khatun6 Dec 2017 9:30 AM IST
      ZURICH: Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand...
      Bayer sticks to bone metastasis drug estimate after setback

      Bayer sticks to bone metastasis drug estimate after setback

      Ruby Khatun Khatun6 Dec 2017 9:15 AM IST
      BERLIN: Bayer is sticking to its peak sales estimate for bone metastasis drug Xofigo despite a setback in a late-stage drug trial, the head of the...
      Nestle, Stada prepare rival bids for Merck consumer health: sources

      Nestle, Stada prepare rival bids for Merck consumer health: sources

      Ruby Khatun Khatun6 Dec 2017 9:00 AM IST
      LONDON/FRANKFURT: Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's...
      New expert panel to help to decide pricing and launch of drugs: DoP

      New expert panel to help to decide pricing and launch of drugs: DoP

      Ruby Khatun Khatun5 Dec 2017 1:43 PM IST
      New Delhi: The government will set up a panel of experts for consultation on matters pertaining to the implementation of the drug price control order,...
      Indian healthcare market to hit 372 billion dollars by 2022: ASSOCHAM-RNCOS

      Indian healthcare market to hit 372 billion dollars by 2022: ASSOCHAM-RNCOS

      Ruby Khatun Khatun5 Dec 2017 11:00 AM IST
      India’s healthcare market may see a threefold rise as its size in value terms is likely to reach $372 billion (bn) by 2022 from the level of $110 bn...
      FDA panel recommends Zika testing of donated blood be relaxed

      FDA panel recommends Zika testing of donated blood be relaxed

      Ruby Khatun Khatun5 Dec 2017 10:45 AM IST
      Advisers to the U.S. Food and Drug Administration on Friday recommended that the requirements for screening blood donations for the Zika virus be...
      FDA approves heart protection claims for Amgen cholesterol drug

      FDA approves heart protection claims for Amgen cholesterol drug

      Ruby Khatun Khatun5 Dec 2017 10:30 AM IST
      Amgen Inc can now promote the ability of its potent but expensive cholesterol drug to reduce the risk of heart attacks and strokes after U.S. health...
      CVS Health to acquire Aetna for 69 billion dollars

      CVS Health to acquire Aetna for 69 billion dollars

      Ruby Khatun Khatun5 Dec 2017 10:15 AM IST
      U.S. drugstore chain operator CVS Health Corp said on Sunday it had agreed to acquire U.S. health insurer Aetna Inc for $69 billion, seeking to tackle...
      Aditya Birla Health Insurance eyes retail growth

      Aditya Birla Health Insurance eyes retail growth

      Ruby Khatun Khatun5 Dec 2017 10:00 AM IST
      New Delhi: Aditya Birla Health Insurance (ABHI), a part of Aditya Birla Capital, is focussing on the retail sector to drive growth.During 2016-17 the...
      Trouble mounts for Sanofi dengue vaccine over safety concerns

      Trouble mounts for Sanofi dengue vaccine over safety concerns

      Ruby Khatun Khatun5 Dec 2017 10:00 AM IST
      The World Health Organization said on Monday it hopes to review safety data on Sanofi’s dengue vaccine this month, while the Philippines ordered an...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok